LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

NVS

150.35

+0.83%↑

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

NVS

150.35

+0.83%↑

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

NVS

150.35

+0.83%↑

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

NVS

150.35

+0.83%↑

AZN

184.71

+0.4%↑

LLY

1,018.6

+3.3%↑

JNJ

229.93

+0.53%↑

ABBV

213.62

+1.94%↑

NVS

150.35

+0.83%↑

AZN

184.71

+0.4%↑

Kodu・Aktsiate loetelu・Ventyx Biosciences Inc

Ventyx Biosciences Inc

Suletud

13.99

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

13.99

Max

13.99

Põhinäitajad
By Trading Economics
Sissetulek	4.2M -23M
Töötajad	83
EBITDA	6.6M -23M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	-4.43% downside

Turustatistika
By TradingEconomics
Turukapital	418M 1B
Eelmine avamishind	13.99
Eelmine sulgemishind	13.99

Ventyx Biosciences Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. märts 2026, 23:12 UTC

Kuumad aktsiad

Stocks to Watch: Adobe, Mission Produce, Buzzfeed, Ulta

12. märts 2026, 22:15 UTC

Tulu

Wheaton Precious Metals Logs Higher 4Q Net Income, Boosts Dividend 18%

12. märts 2026, 21:42 UTC

Uudisväärsed sündmused

Stryker Says Cyberattack Disruption Is Continuing

12. märts 2026, 21:29 UTC

Uudisväärsed sündmused

Correction to War in Iran May Upend Brazil Central Bank's Plans Article

12. märts 2026, 21:27 UTC

Tulu

Adobe CEO to Depart as AI Boosts Sales -- Update

12. märts 2026, 20:46 UTC

Tulu

Adobe Posts Higher Sales With CEO Set to Depart

12. märts 2026, 20:21 UTC

Uudisväärsed sündmused

Soybean Futures Higher on Instability in Iran --Daily Grain Highlights

12. märts 2026, 23:57 UTC

Market Talk

Gold Edges Higher Amid Ongoing Middle East Conflict -- Market Talk

12. märts 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12. märts 2026, 23:38 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Losses -- Market Talk

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas: Tariff Measures, Trade Tensions Weighed on Results >0316.HK

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas: Middle East Situation Have Added to Future Uncertainity >0316.HK

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas: Charter Market Remains Exceptionally Tight With Vessels in Short Supply >0316.HK

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas 2025 Rev $9.72B Vs. $10.70B >0316.HK

12. märts 2026, 22:13 UTC

Tulu

Orient Overseas 2025 Net $1.51B Vs. Net $2.58 >0316.HK

12. märts 2026, 22:13 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

12. märts 2026, 22:13 UTC

Market Talk

Tulu

Adobe Says Customers Want to Try AI Products for Free First -- Market Talk

12. märts 2026, 21:16 UTC

Omandamised, ülevõtmised, äriostud

Alexander & Baldwin: JV Formed by Affil of MW Group and Funds Affiliated With Blackstone and DivcoWest Completed Acquisition of All Outstanding A&B Common Shrs >ALEX

12. märts 2026, 21:04 UTC

Tulu

Adobe Earnings Beat Is Overshadowed by CEO Departure. The Stock Is Sliding. -- Barrons.com

12. märts 2026, 21:02 UTC

Tulu

Wheaton Precious Metals 4Q Adj EPS $1.22 >WPM

12. märts 2026, 21:02 UTC

Tulu

Wheaton Precious Metals 4Q Sales $865M >WPM

12. märts 2026, 21:02 UTC

Tulu

Wheaton Precious Metals 4Q Net $558.3M >WPM

12. märts 2026, 21:02 UTC

Tulu

Wheaton Precious Metals 4Q EPS $1.23 >WPM

12. märts 2026, 20:57 UTC

Market Talk

Uudisväärsed sündmused

No Need For Canada Rate Increases Amid Jump in Bond Yields -- Market Talk

12. märts 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12. märts 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. märts 2026, 20:15 UTC

Omandamised, ülevõtmised, äriostud

Eaton Completes Acquisition Of Leading Liquid-cooling Solutions Provider Boyd Thermal, Creating An Industry-leading Grid-to-chip Solution For Data Centers >ETN

12. märts 2026, 20:10 UTC

Tulu

Adobe Sees 2Q Rev $6.43B-$6.48B >ADBE

12. märts 2026, 20:05 UTC

Tulu

Adobe 1Q Rev $6.4B >ADBE

12. märts 2026, 20:05 UTC

Tulu

Adobe Sees 2Q Adj EPS $5.80-Adj EPS $5.85 >ADBE

Võrdlus sarnastega

Hinnamuutus

Ventyx Biosciences Inc Prognoos

Hinnasiht

By TipRanks

-4.43% langus

12 kuu keskmine prognoos

Keskmine 13.38 USD -4.43%

Kõrge 14 USD

Madal 9 USD

Põhineb 8 Wall Streeti analüütiku instrumendi Ventyx Biosciences Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

Osta

Hoia

Müü

Põhineb 8 analüütiku instrumendi Ventyx Biosciences Inc aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Ettevõttest Ventyx Biosciences Inc

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.